ScinoPharm Taiwan, Ltd. (TPE:1789)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
20.00
+0.10 (0.50%)
Oct 30, 2026, 1:30 PM CST

ScinoPharm Taiwan Financials Overview

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
3,0683,1633,4063,1863,2642,762
Revenue Growth
-3.97%-7.13%6.91%-2.39%18.16%-10.40%
Gross Profit
905.071,0961,3001,2161,2511,280
Operating Income
-68.51108.91321.04314.49405.5288.62
Net Income
37.73136.95339.35287.06353.22243.47
Earnings Per Share
0.050.170.430.360.450.31
EPS Growth
-81.57%-60.39%19.21%-19.41%45.07%-13.68%

Revenue by Segment

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Others
16.1715.8919.9553.4842.6225.99
Changshu Shenlong
333.3389.67679.16645.26494.83482.18
Inter Segment
-293.94-351.04-431.89-519.61-342.84-388.66
Scinopharm Taiwan, Ltd.
3,0123,1093,1393,0073,0692,643
Total
3,0683,1633,4063,1863,2642,762

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
3,4993,1104,1663,9424,2954,081
Total Debt
872.89762.66675.54619.92676.67556.43
Net Cash (Debt)
2,6262,3473,4903,3223,6183,524
Net Cash Growth
11.14%-32.75%5.08%-8.19%2.65%1.31%
Net Cash Per Share
3.322.964.404.194.564.45

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
805.83595.91750.91231.13773.79509.82
Capital Expenditures
-228.79-291.29-280.17-268.43-243.28-314.43
Free Cash Flow
577.04304.62470.74-37.3530.51195.4
Free Cash Flow Growth
135.52%-35.29%--171.50%-74.50%

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
29.50%34.66%38.17%38.17%38.32%46.36%
Operating Margin
-2.23%3.44%9.43%9.87%12.42%10.45%
Pretax Margin
0.29%4.66%12.13%10.95%13.42%10.94%
Profit Margin
1.23%4.33%9.96%9.01%10.82%8.81%
FCF Margin
18.81%9.63%13.82%-1.17%16.25%7.07%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
0.2900.2900.3500.3000.3600.480
Dividend Per Share Growth
-17.14%-17.14%16.67%-16.67%-25.00%-4.00%
Dividend Yield
1.45%1.73%1.59%1.14%1.42%1.95%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
419.1896.7151.3872.7256.9880.06
Forward PE
-44.0858.80102.5252.6030.88
P/FCF Ratio
27.4143.4837.04-37.9399.76
PS Ratio
5.164.195.126.556.177.06